<DOC>
	<DOCNO>NCT02050360</DOCNO>
	<brief_summary>The purpose study determine whether `` on-demand '' sildenafil effective treatment Raynaud 's phenomenon .</brief_summary>
	<brief_title>`` As Required '' Oral Sildenafil Raynaud 's Phenomenon</brief_title>
	<detailed_description />
	<mesh_term>Raynaud Disease</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>Active Raynaud 's Phenomenon characterize clinical history primary secondary Raynaud 's Phenomenon At least 7 RP attack per week 5 day per week ( assessed 2 week precede inclusion ) Patients date sign informed consent form Contraception woman Recently diagnose RP ( less 2 month ) . Uncontrolled hypertension , diabetes mellitus , angina Haemodynamic instability Nonarteritic ischemic optic neuropathy Pulmonary hypertension Subjects currently take sildenafil , tadalafil vardenafil Subjects currently take nitrate Subjects currently take strong CYP3A inhibitor Pregnancy ( consider pregnancy next 4 month ) Breast feed Participation another clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Raynaud 's phenomenon</keyword>
	<keyword>Sildenafil</keyword>
	<keyword>Systemic Sclerosis</keyword>
	<keyword>Local cooling</keyword>
	<keyword>Microcirculation</keyword>
</DOC>